HIV Infographic: Real-time Patient Insights from Medisafe

Infographics
HIV Infographic: Real-time Patient Insights from Medisafe

Highlights from the HIV Infographic

  • The U.S. trails other nations in reported HIV adherence on Medisafe
  • Those on HIV meds are adherent all week long, with Fridays and Saturdays showing slight dips
  • Unlike many therapeutic areas, HIV medication adherence peaks three times daily – in the early morning, 6 pm, and late-night hours
  • Adherence on Medisafe peaks for the 40-50 year age group
  • Across various med classes, ViiV and Gilead have six of the top 10 highest adherence HIV medications reported on Medisafe


What insights can we discover about your brand? Contact us to find out!


Full HIV Adherence Insights

Most Adherent Countries For HIV Meds

  • Canada: 89%
  • Mexico: 88%
  • Spain: 88%
  • Germany: 87%
  • UK: 87%
  • Australia: 86%
  • France: 86%
  • Brazil: 85%
  • USA: 83%

How Day Of Week Affect HIV Med Adherence

  • Sunday: 86%
  • Monday: 86%
  • Tuesday: 86%
  • Wednesday: 85%
  • Thursday: 85%
  • Friday: 84%
  • Saturday: 84%

Adherence Rates By Age Range

  • <20: 84%
  • 20-30: 85%
  • 30-40: 87%
  • 40-50: 88%
  • 50-60: 85%
  • 60+: 87%

Adherence Rates by HIV Med Classification

  • NNRTIs: 85%
  • Protease Inhibitors: 84%
  • Combination HIV Medication: 83%
  • NRTIs: 79%

Top HIV Meds With Highest Adherence

Brand Company Adherence
Sustiva (efavirenz) Bristol-Myers Squibb 87%
Viread (tenofovir) Gilead 86%
Triumeq (dolutegravir + abacavir + lamivudine) ViiV Healthcare 85%
Tivicay (dolutegravir) ViiV Healthcare 85%
Reyataz (atazanavir) Bristol-Myers Squibb 85%
Stribild (Emtriva + Viread + elvitegravir) Gilead 83%
Norvir (ritonavir) AbbVie 83%
Epivir (lamivudine, “3TC”) ViiV Healthcare 83%
Genvoya (elvitegravir) Gilead 83%
Kaletra (lopinavir) AbbVie 82%

What insights can we discover about your brand? Contact us to find out!